Abstract
Letter to the Editor from Kawaguchi: 'Cardiovascular Safety of Romosozumab vs. PTH Analogs for Osteoporosis Treatment: a Propensity Score Matched Cohort Study'.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have